AngioDynamics (ANGO) Reports In-Line Q4 EPS, Offers FY22 Guidance
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $15.88 +1.34%
Financial Fact:
Interest expense: -723K
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Interest expense: -723K
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
AngioDynamics (NASDAQ: ANGO) reported Q4 EPS of $0.00, in-line with the analyst estimate of $0.00. Revenue for the quarter came in at $76.8 million versus the consensus estimate of $72.68 million.
GUIDANCE:
AngioDynamics sees FY2022 EPS of $0.00-$0.05, versus the consensus of $0.05. AngioDynamics sees FY2022 revenue of $305-310 million, versus the consensus of $286.7 million.
For earnings history and earnings-related data on AngioDynamics (ANGO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- 374Water Inc (SCWO) Misses Q2 EPS by 15c
- uCloudlink Group Inc. (UCL) Misses Q2 EPS by 1c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
